Cargando…
Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer
BACKGROUND: Adjuvant endocrine therapy (AET) is prescribed to women for 5–10 years after treatment for estrogen receptor positive (ER+ve), early-stage breast cancer. AET has proven effectiveness in reducing the risk of recurrence of breast cancer and mortality. However, adherence is known to be subo...
Autores principales: | Brett, Jo, Boulton, Mary, Watson, Eila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294163/ https://www.ncbi.nlm.nih.gov/pubmed/30587936 http://dx.doi.org/10.2147/PPA.S187692 |
Ejemplares similares
-
Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence
por: Brett, Jo, et al.
Publicado: (2018) -
Psychometric properties of the Beliefs about Medicine Questionnaire–adjuvant endocrine therapy (BMQ-AET) for women taking AETs following early-stage breast cancer
por: Brett, Jo, et al.
Publicado: (2017) -
Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life
por: Stewart, Sarah-Jane F., et al.
Publicado: (2023) -
Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence
por: Cahir, Caitriona, et al.
Publicado: (2023) -
Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
por: Villarreal-Garza, Cynthia, et al.
Publicado: (2021)